Publication at Second Faculty of Medicine |
2015
Abstract
Insulin remains even now a fundamental cornerstone of diabetes treatment. His discovery and preparation for clinical application has changed the fate of patients diabetes particularly type 1.
It is so far the only anti-diabetic does not pay. The development of dosage forms of insulin continues towards improve patient compliance.
One of these steps is lispro insulin analogue at a concentration of 200 U / ml in pre-filled applicator KwikPen.